Impact of Antiretroviral Therapy on Oxidative Stress in HIV Patients
Author Information
Author(s): Ngondi Judith L, Oben Julius, Forkah David Musoro, Etame Lucten Honore, Mbanya Dora
Primary Institution: University of Yaounde I, Cameroon
Hypothesis
How do different combination therapies affect oxidative stress markers in HIV infected patients?
Conclusion
HIV infection increases oxidative stress, and antiretroviral therapy further exacerbates this effect.
Supporting Evidence
- HIV patients on HAART had significantly higher TBARs levels compared to pre-HAART patients.
- Protein sulfhydryl levels were lower in HIV patients on HAART compared to non-HIV infected controls.
- Therapy I showed a significant reduction in protein sulfhydryl groups compared to other therapies.
Takeaway
HIV makes your body more stressed, and the medicines used to treat it can make that stress even worse.
Methodology
The study involved 240 participants, including HIV positive patients on different therapies and healthy controls, with blood samples analyzed for oxidative stress markers.
Potential Biases
Potential biases in patient selection and reporting of results.
Limitations
The study may not account for all variables affecting oxidative stress, such as diet and lifestyle.
Participant Demographics
85 HIV positive patients on HAART, 65 HIV positive patients not on treatment, and 90 non-HIV infected controls.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website